A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.

MLA

Ferguson, Sherise D., et al. “A Validated Integrated Clinical and Molecular Glioblastoma Long-Term Survival-Predictive Nomogram.” Neuro-Oncology Advances, vol. 3, no. 1, Oct. 2020, p. vdaa146. EBSCOhost, https://doi.org/10.1093/noajnl/vdaa146.

APA

Ferguson, S. D., Hodges, T. R., Majd, N. K., Alfaro-Munoz, K., Al-Holou, W. N., Suki, D., de Groot, J. F., Fuller, G. N., Xue, L., Li, M., Jacobs, C., Rao, G., Colen, R. R., Xiu, J., Verhaak, R., Spetzler, D., Khasraw, M., Sawaya, R., Long, J. P., & Heimberger, A. B. (2020). A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neuro-Oncology Advances, 3(1), vdaa146. https://doi.org/10.1093/noajnl/vdaa146

Chicago

Ferguson, Sherise D, Tiffany R Hodges, Nazanin K Majd, Kristin Alfaro-Munoz, Wajd N Al-Holou, Dima Suki, John F de Groot, et al. 2020. “A Validated Integrated Clinical and Molecular Glioblastoma Long-Term Survival-Predictive Nomogram.” Neuro-Oncology Advances 3 (1): vdaa146. doi:10.1093/noajnl/vdaa146.